fr

Cognition Conversations

Cognition Conversations

Cognition Therapeutics's “Conversations” series will feature virtual fireside chats with neuroscience experts who will discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions. All episodes are available to watch as video as cogrx.com/conversations.

N'hésitez pas à visiter le site du podcast et à soutenir son créateur : cogrx.com

Auteur

Cognition Conversations

Catégorie

Health

Site du podcast

cogrx.com

Dernier épisode

29 mai 2025

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android près de 10 M de téléchargements · note de 4,8 iOS bientôt

Épisodes

Episode 10: Studying the Patient-Caregiver Lived Experience in Dementia with Lewy Bodies 29.05.2025

Featuring: Brendan Kelley, MD (moderator), UT Southwestern Medical Center, Professor and Clinical Vice Chair in the Department of Neurology Samantha K. Holden, MD, MS, FAAN, University of Colorado School of Medicine, Associate Professor of Neurology, Vice Chair for Outpatient Neurology Services Carla Preyer, Salon Owner, Inspirational Speaker, Care Partner to her Husband, Patrick Linda Szypula Ed....

Episode 9: Executing Clinical Research in Dementia with Lewy Bodies (DLB) 23.10.2024

Featuring: Anthony Caggiano, M.D., Ph. D. (moderator), Cognition Therapeutics, Chief Medical Officer James E. Galvin, MD, MPH, University of Miami, Director of the Comprehensive Center for Brain Health, Miller School of Medicine Lawrence S. Honig, MD, PhD, FAAN, Columbia University, Professor of Neurology, Irving Medical Center David Shprecher, D.O., Banner Sun Health Research Institute, Movement...

Episode 8: Protecting the Synapse from Amyloid Toxicity in Alzheimer’s Disease 23.05.2024

Featuring: Anthony Caggiano, M.D., Ph. D. (moderator) Cognition Therapeutics, Chief Medical Officer Mary Hamby, Ph. D. (moderator) Cognition Therapeutics, Vice President of Research Everard (Jort) Vijverberg, MD, PhD Alzheimer Center at Amsterdam University Medical Center, Neurologist and CNS Trial Specialist Tara Spires Jones, DPhil University of Edinburgh, Personal Chair of Neurodegeneration and...

Episode 7: Quantitative EEG: Effects of CT1812 on Measures of Synaptic Function in Alzheimer’s Disease 21.11.2023

Featuring: Anthony Caggiano, M.D., Ph. D. (moderator), Cognition Therapeutics, Chief Medical Officer Willem de Haan, M.D., Ph. D., Alzheimer Center at Amsterdam University Medical Center, Neurologist and Senior Researcher Philip Scheltens, M.D., EQT Life Sciences, Partner and Head of Dementia Fund, Former Director of the Alzheimer Center at Amsterdam University Medical Center Index: 0:00 Introduct...

Episode 6: Geographic Atrophy: New Strategies to Protect the Retina 20.09.2023

Featuring: Anthony Caggiano, M.D., Ph. D., Chief Medical Officer, Cognition Therapeutics C. Gustavo De Moraes, M.D., Ph. D. (moderator), Chief Medical Officer, Ora (CRO), and Associate Professor of Clinical Ophthalmology, Columbia University Jeffrey S. Heier, M.D., Director of the Vitreoretinal Service & Retina Research, Ophthalmic Consultants of Boston Peter K. Kaiser, M.D., Chaney Family End...

Episode 5: Exploring the Effects of CT1812 on Alzheimer’s Disease Processes: Biomarkers and Pathways of Neurodegeneration 25.05.2023

Featuring: Mary Hamby, Ph. D. , Vice President of Research, Cognition Therapeutics Charlotte Teunissen, Ph. D. (moderator), Amsterdam University Medical Center, Professor of Clinical Neurochemistry Nicholas Seyfried, Ph. D. , Emory University School of Medicine, Professor of Biochemistry and Neurology , Director of the Emory Integrated Proteomics Core Henrik Zetterberg, MD, Ph. D. , Gothenburg Uni...

Episode 4: Insights for the Primary Care Physician: Recognizing Dementia with Lewy Bodies 25.05.2023

Featuring: Anthony Caggiano, M.D. , Ph. D., Chief Medical Officer and Head of Research & Development, Cognition Therapeutics Brendan Kelley, M.D. (moderator), University of Texas SW, Vice Chair for Clinical Operations at the Peter O’Donnell Jr. Brain Institute and a Professor in the Department of Neurology Sarah B. Berman, M.D., Ph. D. , University of Pittsburgh, Associate Professor in the Dep...

Episode 3: What if it’s not Alzheimer’s? The Caregiver’s Perspective on Lewy Body Dementia 25.05.2023

Featuring: Lisa Ricciardi , President & Chief Executive Officer, Cognition Therapeutics Norma Loeb , Lewy Body Dementia Resource Center, Founder and Executive Director Mary Lou Falcone , M.L. FALCONE, Public Relations Board member, LBD Resource Center Author of “I Didn’t See It Coming, a Memoir of Love, Loss, and Lewy Body Dementia” Index: 0:00 Introduction 2:30 Key symptoms and signs of Lewy...

Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches 25.05.2023

Featuring: Anthony Caggiano, M.D., Ph. D. , Chief Medical Officer and Head of R&D, Cognition Therapeutics Christopher H. van Dyck, M.D. , Yale University School of Medicine, Professor of Psychiatry, Neurology, and Neuroscience Director of the Division of Aging and Geriatric Psychiatry; Director of the Alzheimer’s Disease Research Center Anton P. Porsteinsson, M.D. , University of Rochester Sch...

Episode 1: Dementia with Lewy Bodies 25.05.2023

Featuring: Anthony Caggiano, M.D., Ph. D. , Chief Medical Officer and Head of R&D, Cognition Therapeutics James Galvin, M.D., MPH , University of Miami Miller School of Medicine, Director of the Comprehensive Center for Brain Health Principal Investigator of the SHIMMER Study Index: 0:00 Introduction 1:09 What is DLB 3:13 Diagnostic Challenges 6:38 Potential Treatment Strategy 7:48 Designing a...

Écoute le podcast Cognition Conversations sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics